Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The agency is able to negotiate some drug prices for Medicare recipients because of a bill signed by former President Joe ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

Low-cost Medicare Part D plans may seem attractive, but restrictive drug lists can lead to unexpected expenses. Knowing the ...

QMedic reports a $2,000 Medicare drug cost cap starting in 2026, ensuring predictable spending and potentially avoiding ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The Trump administration is touting $12 billion in federal savings in Medicare’s second year of drug price negotiations.

The second round of Inflation Reduction Act negotiation prices, which includes 15 brand-name drugs, will kick into effect in ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...